Ferring Pharmaceuticals Ltd

The Courtyard, Waterside Drive, Langley, Berkshire, SL3 6EZ
Telephone: +44 (0)1753 214 800
Fax: +44 (0)1753 214 802
WWW: http://www.ferring.co.uk
Medical Information Direct Line: +44 (0)1753 214 845
Medical Information e-mail: medical@ferring.com
Medical Information Fax: +44 (0)1753 214 801
Summary of Product Characteristics last updated on the eMC: 18/02/2005
SPC Pentasa Mesalazine Enema

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/02/2005 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 22/09/2004 and displayed until 18/02/2005
Reasons for adding or updating:
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects
Updated on 23/12/2003 and displayed until 22/09/2004
Reasons for adding or updating:
  • Change to section 3 - pharmaceutical form
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 (date of (partial) revision of the text
Updated on 04/11/2002 and displayed until 23/12/2003
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Updated on 20/08/2001 and displayed until 04/11/2002
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 13/08/2001 and displayed until 20/08/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 18/01/2001 and displayed until 13/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 18/01/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   mesalazine


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk